5 items found in 1 pages
New Insights from the TARGIT-A trial of radiotherapy during lumpectomy for breast cancer
New Insights from the TARGIT-A trial of radiotherapy during lumpectomy for breast cancer
14
12/1/2021
New insights from the TARGIT-A trial 2021 16min
Invited talk at the Association of Breast Surgeons of India Conference, 26 Nov 2021
15
12/1/2021
New insights from the TARGIT-A trial 5 min for NCRI 2021
TARGIT-IORT for breast cancer NCRI conference Nov 2021 - 5-Min Short talk
13
12/1/2021
TARGIT-IORT radiotherapy during lumpectomy is better for patients 20min
Invited talk at the NHS Oncology Conference 23 Nov 2021
16
12/1/2021
Environmental and Social Benefits of Intrabeam TARGIT IORT for Breast Cancer
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. Nathan J Coombs, Joel M Coombs, Uma J Vaidya, Julian Singer, Max Bulsara, Jeffrey S Tobias, Frederik Wenz, David J Joseph, Douglas A Brown, Richard Rainsbury, Tim Davidson, Douglas J A Adamson, Samuele Massarut, David Morgan, Ingrid Potyka, Tammy Corica, Mary Falzon, Norman Williams, Michael Baum, Jayant S Vaidya BMJ Open 2016;6:e010703. http://bmjopen.bmj.com/content/6/5/e010703.full http://blogs.bmj.com/bmjopen/2016/05/09/radiotherapy-during-surgery-could-save-millions-of-travel-miles-and-tonnes-of-co2/ The use of TARGIT intraoperative radiotherapy for eligible patients with breast cancer significantly reduces their journeys for treatment and has environmental benefits: 5 million miles of travel, 170 000 woman-hours and 1200 tonnes of CO2 (a forest of 100 hectares) per year in the UK
48
11/24/2018